Suboxone is an effective, safe medication approved by the FDA for use in the treatment of opioid addiction. Suboxone contains Buprenorphine and Naloxone. Suboxone is partial opioid agonist, which means that it produces less effect than a full agonist when it binds to opioid receptors in the brain. The way in which opioids affect the brain can be explained using a lock and key analogy. The opioid receptor is like a lock. Only the right key will fit perfectly into the lock, only opioid type drugs fit into the opioid receptors. With full opioid agonists such as methadone, heroin, oxycodone, or morphine, the key will fit the lock perfectly, and fully stimulate the receptor thereby producing full opioid effects such as euphoria or “feeling high” and produces the side effects such as respiratory depression and sedation. These drugs have the greatest abuse potential. With a partial agonist like Buprenorphine, the key fits the lock but not as well as the full opioid agonist, so it produces limited effects, enough to prevent withdrawal and cravings but not enough to cause intense euphoria. Buprenorphine does not allow other opioids to enter the receptor and can also displace other opioids from the receptor.
Suboxone also contains Naloxone which is an opioid antagonist. Opioid antagonists also bind to the receptor, but instead of stimulating the receptor, they effectively block the receptor. An antagonist is like a key that fits into the lock but does not open it and prevents another key from being inserted to open the lock. The Naloxone is in Suboxone to prohibit individuals from injecting it. The injection process will cause the Naloxone to be activated which will cause immediate symptoms of opiate withdrawal. When Suboxone tablet is placed and dissolved under the tongue, the individual will receive the intended benefit of the medication.
The agonist effects of Buprenorphine increase with increasing doses. At a certain point, however, the increasing effects of the Buprenorphine reach maximum levels and do not increase further, even if the dose continues to rise creating a “ceiling effect”. This ceiling effect makes Buprenorphine safer, making it less likely to produce opioid overdose and reducing its potential street value, Buprenorphine carries a lower risk of abuse, addiction, and side effects compared to full opioid agonists.
Focus Treatment Centers offers Suboxone Treatment, providing inpatient medical detoxification program for those struggling with opioid addiction. Suboxone is an effective, safe medication approved by the FDA for use in the treatment of opioid addiction. Suboxone relieves withdrawal symptoms, reduces cravings and blocks the effects of other opioids. It can only be prescribed by physicians specially trained in its usage and licensed specifically by the DEA.
When you choose to work with us, we will help you understand the detoxification process so that you can feel confident about your choice. We are aware making a commitment to begin treatment can be very difficult, but we are here to support you in your new way of living. It is time to Focus on your addiction.